Journal of the Korean Society of Physical Medicine (대한물리의학회지)

The Korean Society of Physical Medicine (대한물리의학회)
권호 표지
DOI QR코드

DOI QR Code

Prevalence, Anthropometric Risk Factors, and Clinical Risk Factors in Sarcopenic Women in Their 40s

  • Received : 2023.04.26
  • Accepted : 2023.05.09
  • Published : 2023.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

PURPOSE: This study examined the anthropometric and clinical risk factors and the prevalence of sarcopenia in women aged 40 to 49 years. METHODS: The study design is a cross-sectional research and a total of 2,055 participants were included. The participants were divided into two groups based on their skeletal muscle mass index score. One hundred and twenty-six individuals were assigned to a sarcopenia group, and 1,939 were assigned to a normal group. The following variables were analyzed: age, height, weight, body mass index, waist circumference, skeletal muscle mass index anthropometric measure, systolic blood pressure, diastolic blood pressure, blood laboratory tests, fasting glucose, triglyceride, total cholesterol, and smoking and drinking smoking statuses. RESULTS: The prevalence of sarcopenia was 6.5% (95% CI: 5.33-7.92). Anthropometric variables, such as height, BMI, and waist circumference, showed significance differences between the two groups (p < .05), except for weight variable (p > .05). In terms of blood pressure and blood lab tests, the systolic blood pressure, diastolic blood pressure, fasting glucose, triglyceride, and total cholesterol were all significant risk factors for sarcopenia in the two groups. (p < .05). CONCLUSION: This study identified risk factors and the prevalence of sarcopenia among community-dwelling middle-aged women.

Keywords

References

  1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S-1S. https://doi.org/10.1093/jn/127.5.990S
  2. Wang C, Bai L. Sarcopenia in the elderly: basic and clinical issues. Geriatr Gerontol Int. 2012;12(3):388-96. https://doi.org/10.1111/j.1447-0594.2012.00851.x
  3. Kulik CT, Ryan S, Harper S, et al. Aging populations and management. Academy of Management Briarcliff Manor, NY. 2014. pp.929-35.
  4. Dam TT, Peters KW, Fragala M, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci. 2014;69(5):584-90. https://doi.org/10.1093/gerona/glu013
  5. Htun NC, Ishikawa-Takata K, Kuroda A, et al. Screening for Malnutrition in Community Dwelling Older Japanese: Preliminary Development and Evaluation of the Japanese Nutritional Risk Screening Tool (NRST). J Nutr Health Aging. 2016;20(2):114-20. https://doi.org/10.1007/s12603-015-0555-3
  6. Han K, Park YM, Kwon HS, et al. Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010. PLoS One. 2014;9(1):e86902.
  7. Cawthon PM, Blackwell TL, Cauley J, et al. Evaluation of the usefulness of consensus definitions of sarcopenia in older men: Results from the Observational Osteoporotic Fractures in Men Cohort Study. J Am Geriatr Soc. 2015;63(11):2247-59. https://doi.org/10.1111/jgs.13788
  8. Pereira FB, Leite AF, de Paula AP. Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men. Archives of Endocrinology Metabolism. 2015;59(1):59-65. https://doi.org/10.1590/2359-3997000000011
  9. Laurent MR, Dedeyne L, Dupont J, et al. Age-related bone loss and sarcopenia in men. Maturitas. 2019;122:51-6. https://doi.org/10.1016/j.maturitas.2019.01.006
  10. Reijnierse EM, de van der Schueren MAE, Trappenburg MC, et al. Lack of knowledge and availability of diagnostic equipment could hinder the diagnosis of sarcopenia and its management. PLoS One. 2017;12(10):e0185837.
  11. Mehiret G, Molla A, Tesfaw A. Knowledge on risk factors and practice of early detection methods of breast cancer among graduating students of Debre Tabor University, Northcentral Ethiopia. BMC Womens Health. 2022;22(1):183.
  12. Hwang J, Park S. Gender-specific risk factors and prevalence for sarcopenia among community-ewelling young-old adults. Intern J of Environ Res and Pub Health. 2022;19(12):7232.
  13. Hwang J, Park S. Sex differences of sarcopenia in an elderly asian population: the prevalence and risk factors. Intern J of Environ Res and Pub Health. 2022;19(19):11980.
  14. Hwang J, Park S. Gender-specific prevalence and risk Factors of sarcopenic obesity in the korean elderly population: A nationwide cross-sectional study. Intern J of Environ Res and Pub Health. 2023;20(2):1140
  15. Lexell J, Downham D, Sjostrom M. Distribution of different fibre types in human skeletal muscles. Fibre type arrangement in m. vastus lateralis from three groups of healthy men between 15 and 83 years. J Neurol Sci. 1986;72(2-3):211-22. https://doi.org/10.1016/0022-510X(86)90009-2
  16. Kehayias JJ, Fiatarone MA, Zhuang H, et al. Total body potassium and body fat: relevance to aging. Am J Clin Nutr. 1997;66(4):904-10. https://doi.org/10.1093/ajcn/66.4.904
  17. Janssen I, Heymsfield SB, Wang ZM, et al. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985). 2000;89(1):81-8. https://doi.org/10.1152/jappl.2000.89.1.81
  18. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889-96. https://doi.org/10.1046/j.1532-5415.2002.50216.x
  19. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. https://doi.org/10.1093/ageing/afy169
  20. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547-58. https://doi.org/10.1093/gerona/glu010
  21. Kweon S, Kim Y, Jang MJ, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43(1):69-77. https://doi.org/10.1093/ije/dyt228
  22. Sanada K, Miyachi M, Tanimoto M, et al. A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol. 2010;110(1):57-65. https://doi.org/10.1007/s00421-010-1473-z
  23. Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290-8. https://doi.org/10.1002/jcsm.12073
  24. Confortin SC, Meneghini V, Ono LM, et al. Anthropometric indicators as a screening tool for sarcopenia in older adults from Florianopolis, Santa Catarina: EpiFloripa Ageing study. Revista De Nutricao-Brazilian Journal of Nutrition. 2017;30(3):287-96. https://doi.org/10.1590/1678-98652017000300002
  25. Zamboni M, Mazzali G, Fantin F, et al. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388-95. https://doi.org/10.1016/j.numecd.2007.10.002
  26. Nair KS. Aging muscle. Am J Clin Nutr. 2005;81(5):953-63. https://doi.org/10.1093/ajcn/81.5.953
  27. Cesari M, Kritchevsky SB, Baumgartner RN, et al. Sarcopenia, obesity, and inflammation--results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am J Clin Nutr. 2005;82(2):428-34. https://doi.org/10.1093/ajcn/82.2.428
  28. Lu CW, Yang KC, Chang HH, et al. Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract. 2013;7(4):e301-7. https://doi.org/10.1016/j.orcp.2012.02.003
  29. Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62(2):253-60. https://doi.org/10.1111/jgs.12652
  30. Androga L, Sharma D, Amodu A, et al. Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease. Kidney Intern Rep. 2017;2(2):201-11. https://doi.org/10.1016/j.ekir.2016.10.008
  31. Abidin Ozturk ZA, Turkbeyler IH, Demir Z, et al. The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. Turk J Phys Med Rehabil. 2018;64(1):72-9. https://doi.org/10.5606/tftrd.2018.1068
  32. Du Y, Oh C, No J. Associations between sarcopenia and metabolic risk factors: a systematic review and meta-analysis. J Obes & Metab Synd. 2018;27(3):175-85. https://doi.org/10.7570/jomes.2018.27.3.175
  33. Cui M, Gang X, Wang G, et al. A cross-sectional study: Associations between sarcopenia and clinical characteristics of patients with type 2 diabetes. Medicine (Baltimore). 2020;99(2):e18708.
  34. Buscemi C, Ferro Y, Pujia R, et al. Sarcopenia and appendicular muscle mass as predictors of Impaired fasting glucose/type 2 diabetes in elderly women. Nutrients. 2021;13(6):1909.
  35. Lundsgaard AM, Kiens B. Gender differences in skeletal muscle substrate metabolism - molecular mechanisms and insulin sensitivity. Front Endocrinol (Lausanne). 2014;5:195.
  36. Buchmann N, Nikolov J, Spira D, et al. Identifying sarcopenia in metabolic syndrome: data from the Berlin aging study II. J Gerontol A Biol Sci Med Sci. 2016;71(2):265-72. https://doi.org/10.1093/gerona/glv089
  37. Du Y, Wang X, Xie H, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria. BMC Endocr Disord. 2019;19(1):109.
  38. Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67-81. https://doi.org/10.1530/JOE-15-0533
  39. Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). 2007;102(3):919-25. https://doi.org/10.1152/japplphysiol.00627.2006
  40. Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity-definition, etiology and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693.
  41. Hashemi R, Shafiee G, Motlagh AD, et al. Sarcopenia and its associated factors in Iranian older individuals: Results of SARIR study. Arch Gerontol Geriatr. 2016;66:18-22. https://doi.org/10.1016/j.archger.2016.04.016
  42. Santos VRd, Araujo MYC, Cardoso MR, et al. Association of insufficient physical activity with sarcopenia and sarcopenic obesity in individuals aged 50 years or more. Revista de Nutricao. 2017;30:175-84. https://doi.org/10.1590/1678-98652017000200003
  43. Huschtscha Z, Parr A, Porter J, et al. Sarcopenic characteristics of active older adults: a cross-sectional Exploration. Sports Med Open. 2021;7(1):32.